quinapril has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gedara, NIM; Jaberi-Douraki, M; Kawakami, J; Meyer, E; Riviere, J; Wyckoff, GJ; Xu, X | 1 |
1 other study(ies) available for quinapril and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Comorbidity; COVID-19; COVID-19 Drug Treatment; Hospital Mortality; Humans; Hypertension; Indoles; Quinapril; Retrospective Studies | 2021 |